149 related articles for article (PubMed ID: 11703290)
1. beta-Catenin expression in the transitional cell zone of pilomatricoma.
Park SW; Suh KS; Wang HY; Kim ST; Sung HS
Br J Dermatol; 2001 Oct; 145(4):624-9. PubMed ID: 11703290
[TBL] [Abstract][Full Text] [Related]
2. Beta-catenin expression in benign and malignant pilomatrix neoplasms.
Hassanein AM; Glanz SM
Br J Dermatol; 2004 Mar; 150(3):511-6. PubMed ID: 15030335
[TBL] [Abstract][Full Text] [Related]
3. beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; Contreras F; Palacios J
Br J Dermatol; 2001 Oct; 145(4):576-81. PubMed ID: 11703283
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of hair and epithelial keratins and transcription factors HOXC13, LEF1, and beta-catenin in a malignant pilomatricoma: a histological and immunohistochemical study.
Cribier B; Worret WI; Braun-Falco M; Peltre B; Langbein L; Schweizer J
J Cutan Pathol; 2006 Jan; 33(1):1-9. PubMed ID: 16441405
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of bone morphogenetic protein-2 in pilomatricoma.
Kurokawa I; Kusumoto K; Bessho K; Okubo Y; Senzaki H; Tsubura A
Br J Dermatol; 2000 Oct; 143(4):754-8. PubMed ID: 11069452
[TBL] [Abstract][Full Text] [Related]
6. Low frequency of beta-catenin gene mutations in pilomatricoma.
Ha SJ; Kim JS; Seo EJ; Lee KH; Lee HJ; Kim JW
Acta Derm Venereol; 2002; 82(6):428-31. PubMed ID: 12575848
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1-dependent induction and nuclear translocation of FHL2 promotes keratin expression in pilomatricoma.
Friedrichs J; Fink D; Mauch C; Kindler D; Hartmann W; Schüle R; Buettner R; Friedrichs N
Virchows Arch; 2015 Feb; 466(2):199-208. PubMed ID: 25477051
[TBL] [Abstract][Full Text] [Related]
8. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas.
Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M
J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715
[TBL] [Abstract][Full Text] [Related]
9. Nuclear localization of beta-catenin in the hair matrix cells and differentiated keratinocytes.
Tsuji H; Ishida-Yamamoto A; Takahashi H; Iizuka H
J Dermatol Sci; 2001 Nov; 27(3):170-7. PubMed ID: 11641056
[TBL] [Abstract][Full Text] [Related]
10. On the regulation of hair keratin expression: lessons from studies in pilomatricomas.
Cribier B; Peltre B; Grosshans E; Langbein L; Schweizer J
J Invest Dermatol; 2004 May; 122(5):1078-83. PubMed ID: 15140206
[TBL] [Abstract][Full Text] [Related]
11. beta-Catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst.
Hassanein AM; Glanz SM; Kessler HP; Eskin TA; Liu C
Am J Clin Pathol; 2003 Nov; 120(5):732-6. PubMed ID: 14608900
[TBL] [Abstract][Full Text] [Related]
12. beta-Catenin gene mutation in human hair follicle-related tumors.
Kajino Y; Yamaguchi A; Hashimoto N; Matsuura A; Sato N; Kikuchi K
Pathol Int; 2001 Jul; 51(7):543-8. PubMed ID: 11472567
[TBL] [Abstract][Full Text] [Related]
13. The Immunohistochemical Patterns of the beta-Catenin Expression in Pilomatricoma.
Kim YS; Shin DH; Choi JS; Kim KH
Ann Dermatol; 2010 Aug; 22(3):284-9. PubMed ID: 20711264
[TBL] [Abstract][Full Text] [Related]
14. A common human skin tumour is caused by activating mutations in beta-catenin.
Chan EF; Gat U; McNiff JM; Fuchs E
Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
[TBL] [Abstract][Full Text] [Related]
15. [Beta-catenin mutations in a common skin cancer: pilomatricoma].
Durand M; Molès JP
Bull Cancer; 1999 Sep; 86(9):725-6. PubMed ID: 10519964
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
Demirkan NC; Bir F; Erdem O; Düzcan E
J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Localization of Phosphorylated and Unphosphorylated Form of β-catenin With Regard to Shadow Cell and Squamous Differentiation in Cutaneous Pilomatricoma.
Nakamura T; Fujiwara M
Am J Dermatopathol; 2020 Nov; 42(11):835-841. PubMed ID: 32310857
[TBL] [Abstract][Full Text] [Related]
18. Differentiation and apoptosis in pilomatrixoma.
Ishige T; Kikuchi K; Miyazaki Y; Hara H; Yoshino A; Terui T; Katayama Y; Kusama K; Nemoto N
Am J Dermatopathol; 2011 Feb; 33(1):60-4. PubMed ID: 21239898
[TBL] [Abstract][Full Text] [Related]
19. Skin tumors with matrical differentiation: lessons from hair keratins, beta-catenin and PHLDA-1 expression.
Battistella M; Carlson JA; Osio A; Langbein L; Cribier B
J Cutan Pathol; 2014 May; 41(5):427-36. PubMed ID: 24673383
[TBL] [Abstract][Full Text] [Related]
20. Basal cell carcinoma and pilomatrixoma mirror human follicular embryogenesis as reflected by their differential expression patterns of SOX9 and β-catenin.
Krahl D; Sellheyer K
Br J Dermatol; 2010 Jun; 162(6):1294-301. PubMed ID: 20105172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
